Remote diagnostic platforms to simulate Animal Health
Wearable technology is set to emerge as one of the potential solutions to ensure medical assistance services for all. Common applications include managing multiple health conditions through wearable devices, preventive care in intensive care and elderly patients, and providing quality remote care to various patients in remote areas or homes. care, etc. This would be driving the Animal Health Active Pharmaceutical Ingredients market over the forecast period.
According to a recent study by Persistence Market Research (PMR), the global active pharmaceutical ingredients (API) market for animal health is expected to register an impressive expansion at 7.3% CAGR during the forecast period 2017 to 2025. PMR research estimates the market to grow from revenue of US$5,216.1 million in 2017 to US$9,162.2 million by the end of 2025.
Access Free Sample Animal Health Active Pharmaceutical Ingredients Market Report @ https://www.persistencemarketresearch.com/samples/16972
Glenmark Pharmaceutical Ltd.
Eli Lilly & Co.
Sanofi Winthrop Industry (CEPiA)
P&R SpA (Olon SpA)
Lonza Group AG
fine gold animal health
Blanver Farmoquimica E Farmaceutica SA
Zhejiang Hisun Pharmaceutical Co.Ltd
Changzhou Yabang-Qh Pharmachem Co., Ltd.
Shanghai Pharmtech Co.Ltd.
Ningxia Tairui Pharma CO. ltd.
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Sequent Scientific Ltd.
NGL Fine Chem Ltd.
Omkar Specialty Chemicals Limited
Excel Industries Ltd.
How about revitalizing the strategy-driven funnel to stay ahead of the animal health active pharmaceutical ingredient market @ https://www.persistencemarketresearch.com/methodology/16972
Limited insurance or government intervention ensure smooth flow towards market growth in APAC
Asia-Pacific (APAC) will continue to be the most lucrative region in the global active pharmaceutical ingredients market for animal health, with sales showing the second highest CAGR through 2025. APAC remained the one of the largest API providers, at affordable costs.
APAC governments have made investments and focused on local API manufacturing facilities. The favorable policies offered by these governments have shifted the focus of API manufacturers by shifting their production bases to APAC countries, such as India and China.
Also, limited insurance or government intervention ensures smooth flow towards market growth in these regions.
However, animal health API products produced in APAC countries do not meet regulatory standards, and there are growing concerns about the quality of APIs, especially those produced in China and India. Western regulators are increasingly strict in inspecting APIs produced in these regions.
Manufacturers also face challenges in bridging the gap between API cost and quality. These factors will inhibit the market growth in APAC.
Europe will remain the second largest market for animal health APIs
Europe will remain the second largest market for active pharmaceutical ingredients for animal health. Major healthcare companies are located in Europe, which in turn has increased the need for veterinary APIs in the region. The consumption of veterinary medicinal products in Europe has increased considerably in recent years. Spain is the largest consumer of veterinary antimicrobial APIs in the EU.
Also, the increasing improvements in animal productivity have spurred the growth of the animal health industry in this region. These implications are expected to increase the growth of the animal health API market in Europe.
However, the pharmaceutical industry in Europe has become concerned about the potential short-term impacts of the REACH regulation. This will likely lead to a decrease in the supply of materials, or reagents, that are not pre-registered by EU suppliers.
In addition, dynamic changes in Europe’s macroeconomic environment, such as Brexit, have impacted intra-European trade and the pharmaceutical sector as a whole. These factors could restrain the growth of the Animal Health API market in Europe.
Pesticides will remain the largest APIs adopted in the market
Pesticides will continue to be the largest API adopted in the market, followed by anti-infectives. Antiparasitic sales are expected to experience the fastest expansion, to account for the largest revenues by the end of 2025. In contrast, revenue from sales of anesthetics and NSAIDs will remain relatively lower than that of parasiticides and anti-infectives.
Regional Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (United States, Canada, Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
Asia-Pacific (China, India, Japan, Southeast Asia, etc.)
South America (Brazil, Argentina etc.)
Middle East and Africa (Saudi Arabia, South Africa, etc.)
Go to “Buy Now” to get our Animal Health Active Pharmaceutical Ingredients Market Report! https://www.persistencemarketresearch.com/checkout/16972
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York,
NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]
About Us :-
Persistence Market Research is here to provide businesses with a one-stop solution when it comes to improving customer experience. It is committed to gathering appropriate feedback after going through personalized customer interactions to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. The best possible yields are guaranteed.
This press release was published on openPR.